- Home
- ARGX vs ROL Comparison
ARGX vs ROL Comparison
Compare ARGX & ROL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARGX
- ROL
- Stock Information
- Founded
- ARGX 2008
- ROL 1948
- Country
- ARGX Netherlands
- ROL United States
- Employees
- ARGX N/A
- ROL N/A
- Industry
- ARGX Biotechnology: Biological Products (No Diagnostic Substances)
- ROL Diversified Commercial Services
- Sector
- ARGX Health Care
- ROL Finance
- Exchange
- ARGX Nasdaq
- ROL Nasdaq
- Market Cap
- ARGX 26.5B
- ROL 23.5B
- IPO Year
- ARGX 2017
- ROL N/A
- Fundamental
- Price
- ARGX $542.00
- ROL $49.59
- Analyst Decision
- ARGX Strong Buy
- ROL Buy
- Analyst Count
- ARGX 20
- ROL 6
- Target Price
- ARGX $544.06
- ROL $47.83
- AVG Volume (30 Days)
- ARGX 290.6K
- ROL 1.3M
- Earning Date
- ARGX 10-29-2024
- ROL 10-23-2024
- Dividend Yield
- ARGX N/A
- ROL 1.21%
- EPS Growth
- ARGX N/A
- ROL 19.97
- EPS
- ARGX N/A
- ROL 0.95
- Revenue
- ARGX $1,659,620,000.00
- ROL $3,234,782,000.00
- Revenue This Year
- ARGX $60.97
- ROL $10.89
- Revenue Next Year
- ARGX $41.19
- ROL $8.27
- P/E Ratio
- ARGX N/A
- ROL $52.32
- Revenue Growth
- ARGX 98.69
- ROL 12.72
- 52 Week Low
- ARGX $327.73
- ROL $32.19
- 52 Week High
- ARGX $552.83
- ROL $51.28
- Technical
- Relative Strength Index (RSI)
- ARGX 66.68
- ROL 51.51
- Support Level
- ARGX $512.04
- ROL $49.70
- Resistance Level
- ARGX $552.83
- ROL $51.28
- Average True Range (ATR)
- ARGX 8.80
- ROL 0.84
- MACD
- ARGX -0.24
- ROL 0.03
- Stochastic Oscillator
- ARGX 73.99
- ROL 47.52
About ARGX argenx SE
Argenx is a Dutch company focused on using its antibody engineering technology to treat rare autoimmune diseases. Vyvgart (efgartigimod) was approved in the U.S. in December 2021 as a treatment for generalized myasthenia gravis, followed by approvals in Europe and Japan in 2022.
About ROL Rollins Inc.
Rollins is a global leader in route-based pest-control services, with operations spanning North, Central and South America, Europe, the Middle East and Africa and Australia. Its portfolio of pest-control brands includes the prominent Orkin brand, market leader in the U.S., where it boasts near national coverage, and in Canada. Residential pest and termite prevention dominates the services provided by Rollins, owing to the group's ongoing focus on U.S. and Canadian markets.